NVG, LLC for PFIZER INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Intellectual property, data exclusivity, and patent eligibility, generally; Affordable Prescriptions for Patients Act of 2021 (S. 1435/H.R. 2873).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA F. HURVITZ | — |
| ANDREA LARUE | — |
Budget/Appropriations BUD
Issues related to improving immunization information systems, promoting vaccine confidence, enhancing immunization data collection, and Lyme disease in the FY 2022 LHHS Appropriations bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA GERMAN FOSTER | — |
| JANE LOEWENSON | — |
Health Issues HCR
Prescription drug coverage and payment policies; Protecting Seniors Through Immunization Act (S. 912/H.R. 1978); Medical innovation issues; Manufacturing API, Drugs, and Excipients Act (S. 2082/H.R. 3927); Mitigate drug shortages; Provide incentives for manufacturing pharmaceutical ingredients, devices, pharmaceuticals, and PPE in the U.S.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA GERMAN FOSTER | — |
| BRADY KING | — |
| ANDREA LARUE | — |
| EDEN SHIFERAW | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.